Zyla Life Sciences US Inc.

FDA Regulatory Profile

Zyla Life Sciences US Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0094-2024, Class III) was initiated on October 20, 2023.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0094-2024Class IIIOxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla LOctober 20, 2023